Clinical-stage microbiome therapeutics company.
| Date | Round | Amount |
|---|---|---|
| Apr 2024 | Funding round EnteroBiotix, a Glasgow microbiome-therapeutics biotech, closed a GBP27M round (GBP15.7M equity plus loan-note conversion). | $31.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.